Archives of Endocrinology and Metabolism

Archives of Endocrinology and Metabolism

WoS IF 2024 - 2.3
Scimago SJR - 0.429
h5 Index - 26 Qualis - B2
How to submit your article?
Submit
  • About
    About the Journal Cookies Policy
  • Editorial Board
  • Available Issues
  • Instructions for Authors

Archives of Endocrinology and Metabolism

  • About
    • About the Journal
    • Cookies Policy
  • Editorial Board
  • Available Issues
  • Instructions for Authors
  1. Home
  2. Available Issues
  3. Table of Contents

Volume 56, Number 8, 2012

  • Previous
  • Next

EDITORIAL

Special issue on molecular genetics in endocrinology

Monalisa F.
Azevedo
,
Regina S.
Moisés
,
Sonir R. R.
Antonini

25
Special issue on molecular genetics in endocrinology

November/2012

Special issue on molecular genetics in endocrinology

Monalisa F.
Azevedo
,
Regina S.
Moisés
,
Sonir R. R.
Antonini

DOI: 10.1590/S0004-27302012000800001

25
More

original articles

Analysis of anti-Müllerian hormone (AMH) and its receptor (AMHR2) genes in patients with persistent Müllerian duct syndrome

Mirian Yumie
Nishi
,
Sorahia
Domenice
,
Andréa Trevas
Maciel-Guerra
,
Alberto Zaba
Neto
,
Marcia Alessandra Cavalaro Pereira da
Silva
,
[...], Berenice Bilharinho de
Mendonca

46
Analysis of anti-Müllerian hormone (AMH) and its receptor (AMHR2) genes in patients with persistent Müllerian duct syndrome

Analysis of anti-Müllerian hormone (AMH) and its receptor (AMHR2) genes in patients with persistent Müllerian duct syndrome

Mirian Yumie
Nishi
,
Sorahia
Domenice
,
Andréa Trevas
Maciel-Guerra
,
Alberto Zaba
Neto
,
Marcia Alessandra Cavalaro Pereira da
Silva
,
[...], Berenice Bilharinho de
Mendonca

DOI: 10.1590/S0004-27302012000800002

OBJECTIVE: To screen for mutations in AMH and AMHR2 genes in patients with persistent Müllerian duct syndrome (PMDS). PATIENTS AND METHOD: Genomic DNA of eight patients with PMDS was obtained from peripheral blood leukocytes. Directed sequencing of the coding regions and the exon-intron boundaries of AMH and AMHR2 were performed. RESULTS: The AMH mutations p.Arg95*, p.Arg123Trp, c.556-2A>G, and p.Arg502Leu were identified in five patients; and p.Gly323Ser and p.Arg407* in AMHR2 of two individuals. In silico analyses of the novel c.556-2A>G, […]

Keywords: AMH; AMHR2; Anti-Müllerian hormone; hernia inguinalis; persistent Müllerian duct syndrome

46
More

Association of the rs7903146 single nucleotide polymorphism at the Transcription Factor 7-like 2 (TCF7L2) locus with type 2 diabetes in Brazilian subjects

Gustavo Barcelos
Barra
,
Ludmila Alves Sanches
Dutra
,
Sílvia Conde
Watanabe
,
Patrícia Godoy Garcia
Costa
,
Patrícia Sales Marques da
Cruz
,
[...], Angélica Amorim
Amato

29
Association of the rs7903146 single nucleotide polymorphism at the Transcription Factor 7-like 2 (TCF7L2) locus with type 2 diabetes in Brazilian subjects

Association of the rs7903146 single nucleotide polymorphism at the Transcription Factor 7-like 2 (TCF7L2) locus with type 2 diabetes in Brazilian subjects

Gustavo Barcelos
Barra
,
Ludmila Alves Sanches
Dutra
,
Sílvia Conde
Watanabe
,
Patrícia Godoy Garcia
Costa
,
Patrícia Sales Marques da
Cruz
,
[...], Angélica Amorim
Amato

DOI: 10.1590/S0004-27302012000800003

OBJECTIVE:To investigate the association of the T allele of the single nucleotide polymorphism (SNP) rs7903146 of TCF7L2 with the occurrence of T2D in a sample of subjects followed up at the Brasilia University Hospital. SUBJECTS AND METHODS: The SNP rs7903146 of TCF7L2 was genotyped by allele-specific PCR in 113 patients with known T2D and in 139 non-diabetic controls in Brasilia, Brazil. RESULTS:We found that the T allele of the SNP rs7903146 of TCF7L2 was significantly associated with T2D risk (odds […]

Keywords: rs7903146; single nucleotide polymorphism; TCF7L2; type 2 diabetes

29
More

case reports

Hyperinsulinism/hyperammonemia (HI/HA) syndrome due to a mutation in the glutamate dehydrogenase gene

Maria Lúcia
Corrêa-Giannella
,
Daniel Soares
Freire
,
Ana Mercedes
Cavaleiro
,
Maria Angela Zanella
Fortes
,
Ricardo Rodrigues
Giorgi
,
Maria Adelaide Albergaria
Pereira

118
Hyperinsulinism/hyperammonemia (HI/HA) syndrome due to a mutation in the glutamate dehydrogenase gene

Hyperinsulinism/hyperammonemia (HI/HA) syndrome due to a mutation in the glutamate dehydrogenase gene

Maria Lúcia
Corrêa-Giannella
,
Daniel Soares
Freire
,
Ana Mercedes
Cavaleiro
,
Maria Angela Zanella
Fortes
,
Ricardo Rodrigues
Giorgi
,
Maria Adelaide Albergaria
Pereira

DOI: 10.1590/S0004-27302012000800004

The hyperinsulinism/hyperammonemia (HI/HA) syndrome is a rare autosomal dominant disease manifested by hypoglycemic symptoms triggered by fasting or high-protein meals, and by elevated serum ammonia. HI/HA is the second most common cause of hyperinsulinemic hypoglycemia of infancy, and it is caused by activating mutations in GLUD1, the gene that encodes mitochondrial enzyme glutamate dehydrogenase (GDH). Biochemical evaluation, as well as direct sequencing of exons and exon-intron boundary regions of the GLUD1 gene, were performed in a 6-year old female patient […]

118
More

Clinical follow-up of two Brazilian subjects with glucokinase-MODY (MODY2) with description of a novel mutation

Thais
DellaManna
,
Magnus R. da
Silva
,
Antonio Roberto
Chacra
,
Ilda S.
Kunii
,
Ana Luiza
Rolim
,
[...], André Fernandes
Reis

38
Clinical follow-up of two Brazilian subjects with glucokinase-MODY (MODY2) with description of a novel mutation

Clinical follow-up of two Brazilian subjects with glucokinase-MODY (MODY2) with description of a novel mutation

Thais
DellaManna
,
Magnus R. da
Silva
,
Antonio Roberto
Chacra
,
Ilda S.
Kunii
,
Ana Luiza
Rolim
,
[...], André Fernandes
Reis

DOI: 10.1590/S0004-27302012000800005

Mutations in the glucokinase gene (GCK) account for many cases of monogenic diabetes featuring maturity-onset diabetes of the young type 2 (MODY2). The clinical pattern of this form of hyperglycemia is rather stable, with a slight elevation in blood glucose, which is usually not progressive. Patients rarely require pharmacological interventions and microvascular complications related to diabetes are unusual. We describe the clinical follow-up of two cases of MODY2 with two different mutations in GCK gene, one in exon 7, p.Glu265Lys […]

38
More

A novel DAX1/NR0B1 mutation in a patient with adrenal hypoplasia congenita and hypogonadotropic hypogonadism

Claudilene
Battistin
,
Hamilton Cabral de Menezes
Filho
,
Sorahia
Domenice
,
Mirian Yumie
Nishi
,
Thais Della
Manna
,
[...], Durval
Damiani

59
A novel DAX1/NR0B1 mutation in a patient with adrenal hypoplasia congenita and hypogonadotropic hypogonadism

A novel DAX1/NR0B1 mutation in a patient with adrenal hypoplasia congenita and hypogonadotropic hypogonadism

Claudilene
Battistin
,
Hamilton Cabral de Menezes
Filho
,
Sorahia
Domenice
,
Mirian Yumie
Nishi
,
Thais Della
Manna
,
[...], Durval
Damiani

DOI: 10.1590/S0004-27302012000800006

We report a case of adrenal hypoplasia congenita (AHC) and hypogonadotropic hypogonadism (HH) due to a novel DAX1 mutation. A 19-month-old boy with hyperpigmentation and failure to thrive came to our service for investigation. Three brothers of the patient had died due to adrenal failure, and a maternal cousin had adrenal insufficiency. Adrenoleukodystrophy was excluded. MRI showed normal pituitary and hypothalamus. Plasma hormone evaluation revealed high ACTH (up to 2,790 pg/mL), and low levels of androstenedione, DHEA-S, 11-deoxycortisol, and cortisol. […]

59
More

Resistance to octreotide LAR in acromegalic patients with high SSTR2 expression: analysis of AIP expression

Leandro
Kasuki
,
Leandro M.
Colli
,
Paula C. L.
Elias
,
Margaret de
Castro
,
Mônica R.
Gadelha

45
Resistance to octreotide LAR in acromegalic patients with high SSTR2 expression: analysis of AIP expression

Resistance to octreotide LAR in acromegalic patients with high SSTR2 expression: analysis of AIP expression

Leandro
Kasuki
,
Leandro M.
Colli
,
Paula C. L.
Elias
,
Margaret de
Castro
,
Mônica R.
Gadelha

DOI: 10.1590/S0004-27302012000800007

We present here the clinical and molecular data of two patients with acromegaly treated with octreotide LAR after non-curative surgery, and who presented different responses to therapy. Somatostatin receptor type 2 and 5 (SSTR2 and SSTR5), and aryl hydrocarbon receptor-interacting protein (AIP) expression levels were analyzed by qPCR. In both cases, high SSTR2 and low SSTR5 expression levels were detected; however, only one of the patients achieved disease control after octreotide LAR therapy. When we analyzed AIP expression levels of […]

45
More

Genetic studies in a coexistence of acromegaly, pheochromocytoma, gastrointestinal stromal tumor (GIST) and thyroid follicular adenoma

César Luiz
Boguszewski
,
Tayane Muniz
Fighera
,
Andressa
Bornschein
,
Fabricio Machado
Marques
,
Judit
Dénes
,
[...], Marta
Korbonits

36
Genetic studies in a coexistence of acromegaly, pheochromocytoma, gastrointestinal stromal tumor (GIST) and thyroid follicular adenoma

Genetic studies in a coexistence of acromegaly, pheochromocytoma, gastrointestinal stromal tumor (GIST) and thyroid follicular adenoma

César Luiz
Boguszewski
,
Tayane Muniz
Fighera
,
Andressa
Bornschein
,
Fabricio Machado
Marques
,
Judit
Dénes
,
[...], Marta
Korbonits

DOI: 10.1590/S0004-27302012000800008

We report on an adult woman with rare coexistence of acromegaly, pheochromocytoma (PHEO), gastrointestinal stromal tumor (GIST), intestinal polyposis, and thyroid follicular adenoma. At the age of 56, she was diagnosed with acromegaly caused by a pituitary macroadenoma, treated by transsphenoidal surgery, radiotherapy, and octreotide. During routine colonoscopy, multiple polyps were identified as tubular adenomas with high-grade dysplasia on histology. Years later, an abdominal mass of 8.0 x 6.2 cm was detected by routine ultrasound. Surgical exploration revealed an adrenal […]

36
More

Severe congenital non-autoimmune hyperthyroidism associated to a mutation in the extracellular domain of thyrotropin receptor gene

Paula A.
Scaglia
,
Ana
Chiesa
,
Gabriela
Bastida
,
Mirta
Pacin
,
Horacio M.
Domené
,
Laura
Gruñeiro-Papendieck

38
Severe congenital non-autoimmune hyperthyroidism associated to a mutation in the extracellular domain of thyrotropin receptor gene

Severe congenital non-autoimmune hyperthyroidism associated to a mutation in the extracellular domain of thyrotropin receptor gene

Paula A.
Scaglia
,
Ana
Chiesa
,
Gabriela
Bastida
,
Mirta
Pacin
,
Horacio M.
Domené
,
Laura
Gruñeiro-Papendieck

DOI: 10.1590/S0004-27302012000800009

Activating mutations in the TSH Receptor (TSHR) gene have been identified as the molecular basis for congenital non-autoimmune hyperthyroidism. We describe the clinical findings and molecular characterization in a girl who presented severe non-autoimmune hyperthyroidism since birth, born to a mother with autoimmune thyroid disease. She was treated with methylmercaptoimidazol and ?-blockers, but remained hyperthyroid and required total thyroidectomy. To characterize the presence of an activating mutation, the whole coding sequence and intron-exon boundaries of TSHR gene were analyzed. The […]

38
More

Incidental mild hyperglycemia in children: two MODY 2 families identified in Brazilian subjects

Lílian A.
Caetano
,
Alexander A. L.
Jorge
,
Alexsandra C.
Malaquias
,
Ericka B.
Trarbach
,
Márcia S.
Queiroz
,
[...], Milena G.
Teles

41
Incidental mild hyperglycemia in children: two MODY 2 families identified in Brazilian subjects

Incidental mild hyperglycemia in children: two MODY 2 families identified in Brazilian subjects

Lílian A.
Caetano
,
Alexander A. L.
Jorge
,
Alexsandra C.
Malaquias
,
Ericka B.
Trarbach
,
Márcia S.
Queiroz
,
[...], Milena G.
Teles

DOI: 10.1590/S0004-27302012000800010

Maturity-onset diabetes of the young (MODY) is characterized by an autosomal dominant mode of inheritance, early onset of hyperglycemia, and defects of insulin secretion. MODY subtypes described present genetic, metabolic, and clinical differences. MODY 2 is characterized by mild asymptomatic fasting hyperglycemia, and rarely requires pharmacological treatment. Hence, precise diagnosis of MODY is important for determining management and prognosis. We report two heterozygous GCK mutations identified during the investigation of short stature. Case 1: a prepubertal 14-year-old boy was evaluated […]

41
More

Frasier syndrome: four new cases with unusual presentations

Mara Sanches
Guaragna
,
Anna Cristina Gervásio de Britto
Lutaif
,
Viviane Barros
Bittencourt
,
Cristiane Santos Cruz
Piveta
,
Fernanda Caroline
Soardi
,
[...], Maricilda Palandi De
Mello

53
Frasier syndrome: four new cases with unusual presentations

Frasier syndrome: four new cases with unusual presentations

Mara Sanches
Guaragna
,
Anna Cristina Gervásio de Britto
Lutaif
,
Viviane Barros
Bittencourt
,
Cristiane Santos Cruz
Piveta
,
Fernanda Caroline
Soardi
,
[...], Maricilda Palandi De
Mello

DOI: 10.1590/S0004-27302012000800011

Frasier syndrome (FS) is characterized by gonadal dysgenesis and nephropathy. It is caused by specific mutations in the Wilms’ tumor suppressor gene (WT1) located in 11p23. Patients with the 46,XY karyotype present normal female genitalia with streak gonads, and have higher risk of gonadal tumor, mainly, gonadoblastoma. Therefore, elective bilateral gonadectomy is indicated. Nephropathy in FS consists in nephrotic syndrome (NS) with proteinuria that begins early in childhood and progressively increases with age, mainly due to nonspecific focal and segmental […]

53
More

Clinical and molecular spectrum of patients with 17?-hydroxysteroid dehydrogenase type 3 (17-?-HSD3) deficiency

Carla Cristina Telles de Sousa
Castro
,
Guilherme
Guaragna-Filho
,
Flavia Leme
Calais
,
Fernanda Borchers
Coeli
,
Ianik Rafaela Lima
Leal
,
[...], Gil
Guerra-Junior

36
Clinical and molecular spectrum of patients with 17?-hydroxysteroid dehydrogenase type 3 (17-?-HSD3) deficiency

Clinical and molecular spectrum of patients with 17?-hydroxysteroid dehydrogenase type 3 (17-?-HSD3) deficiency

Carla Cristina Telles de Sousa
Castro
,
Guilherme
Guaragna-Filho
,
Flavia Leme
Calais
,
Fernanda Borchers
Coeli
,
Ianik Rafaela Lima
Leal
,
[...], Gil
Guerra-Junior

DOI: 10.1590/S0004-27302012000800012

The enzyme 17?-hydroxysteroid dehydrogenase type 3 (17-?-HSD3) catalyzes the conversion of androstenedione to testosterone in the testes, and its deficiency is a rare disorder of sex development in 46,XY individuals. It can lead to a wide range of phenotypic features, with variable hormonal profiles. We report four patients with the 46,XY karyotype and 17-?-HSD3 deficiency, showing different degrees of genital ambiguity, increased androstenedione and decreased testosterone levels, and testosterone to androstenedione ratio < 0.8. In three of the patients, diagnosis […]

36
More

Novel mutation in the gonadotropin-releasing hormone receptor (GNRHR) gene in a patient with normosmic isolated hypogonadotropic hypogonadism

Daiane
Beneduzzi
,
Ericka B.
Trarbach
,
Ana Claudia
Latronico
,
Berenice Bilharinho de
Mendonca
,
Letícia F. G.
Silveira

47
Novel mutation in the gonadotropin-releasing hormone receptor (GNRHR) gene in a patient with normosmic isolated hypogonadotropic hypogonadism

Novel mutation in the gonadotropin-releasing hormone receptor (GNRHR) gene in a patient with normosmic isolated hypogonadotropic hypogonadism

Daiane
Beneduzzi
,
Ericka B.
Trarbach
,
Ana Claudia
Latronico
,
Berenice Bilharinho de
Mendonca
,
Letícia F. G.
Silveira

DOI: 10.1590/S0004-27302012000800013

We report a novel GNRHR mutation in a male with normosmic isolated hypogonadotropic hypogonadism (nIHH). The coding region of the GNRHR gene was amplified and sequenced. Three variants p.[Asn10Lys;Gln11Lys]; [Tyr283His] were identified in the GNRHR coding region in a male with sporadic complete nIHH. The three variants were absent in the controls (130 normal adults). Familial segregation showed that the previously described p.Asn10Lys and p.Gln11Lys are in the same allele, in compound heterozygozity with the novel variant p.Tyr283His. The p.[Asn10Lys;Gln11Lys] […]

47
More

The use of fluorescence in situ hybridization in the diagnosis of hidden mosaicism: apropos of three cases of sex chromosome anomalies

Andréa Trevas
Maciel-Guerra
,
Juliana De
Paulo
,
Ana Paula
Santos
,
Guilherme
Guaragna-Filho
,
Juliana Gabriel Ribeiro
Andrade
,
[...], Gil
Guerra-Júnior

99
The use of fluorescence in situ hybridization in the diagnosis of hidden mosaicism: apropos of three cases of sex chromosome anomalies

The use of fluorescence in situ hybridization in the diagnosis of hidden mosaicism: apropos of three cases of sex chromosome anomalies

Andréa Trevas
Maciel-Guerra
,
Juliana De
Paulo
,
Ana Paula
Santos
,
Guilherme
Guaragna-Filho
,
Juliana Gabriel Ribeiro
Andrade
,
[...], Gil
Guerra-Júnior

DOI: 10.1590/S0004-27302012000800014

FISH has been used as a complement to classical cytogenetics in the detection of mosaicism in sex chromosome anomalies. The aim of this study is to describe three cases in which the final diagnosis could only be achieved by FISH. Case 1 was an 8-year-old 46,XY girl with normal female genitalia referred to our service because of short stature. FISH analysis of lymphocytes with probes for the X and Y centromeres identified a 45,X/46,X,idic(Y) constitution, and established the diagnosis of […]

99
More

MicroRNAs miR-146-5p and let-7f as prognostic tools for aggressive papillary thyroid carcinoma: a case report

Murilo Vieira
Geraldo
,
Cesar Seigi
Fuziwara
,
Celso Ubirajara Moretto
Friguglieti
,
Ricardo Borges
Costa
,
Marco Aurélio Vamondes
Kulcsar
,
[...], Edna Teruko
Kimura

51
MicroRNAs miR-146-5p and let-7f as prognostic tools for aggressive papillary thyroid carcinoma: a case report

MicroRNAs miR-146-5p and let-7f as prognostic tools for aggressive papillary thyroid carcinoma: a case report

Murilo Vieira
Geraldo
,
Cesar Seigi
Fuziwara
,
Celso Ubirajara Moretto
Friguglieti
,
Ricardo Borges
Costa
,
Marco Aurélio Vamondes
Kulcsar
,
[...], Edna Teruko
Kimura

DOI: 10.1590/S0004-27302012000800015

Papillary thyroid cancer (PTC) is the most incident histotype of thyroid cancer. A certain fraction of PTC cases (5%) are irresponsive to conventional treatment, and refractory to radioiodine therapy. The current prognostic factors for aggressiveness are mainly based on tumor size, the presence of lymph node metastasis, extrathyroidal invasion and, more recently, the presence of the BRAFT1799A mutation. MicroRNAs (miRNAs) have been described as promising molecular markers for cancer as their deregulation is observed in a wide range of tumors. […]

51
More

Type IA isolated growth hormone deficiency (IGHD) consistent with compound heterozygous deletions of 6.7 and 7.6 Kb at the GH1 gene locus

Ana
Keselman
,
Paula A.
Scaglia
,
María Soledad Rodríguez
Prieto
,
María Gabriela
Ballerini
,
María Eugenia
Rodríguez
,
[...], Horacio M.
Domené

21
Type IA isolated growth hormone deficiency (IGHD) consistent with compound heterozygous deletions of 6.7 and 7.6 Kb at the GH1 gene locus

Type IA isolated growth hormone deficiency (IGHD) consistent with compound heterozygous deletions of 6.7 and 7.6 Kb at the GH1 gene locus

Ana
Keselman
,
Paula A.
Scaglia
,
María Soledad Rodríguez
Prieto
,
María Gabriela
Ballerini
,
María Eugenia
Rodríguez
,
[...], Horacio M.
Domené

DOI: 10.1590/S0004-27302012000800016

Isolated growth hormone deficiency (IGHD) may result from deletions/mutations in either GH1 or GHRHR genes. The objective of this study was to characterize the molecular defect in a girl presenting IGHD. The patient was born at 41 weeks of gestation from non-consanguineous parents. Clinical and biochemical evaluation included anthropometric measurements, evaluation of pituitary function, IGF-I and IGFBP-3 levels. Molecular characterization was performed by PCR amplification of GH1 gene and SmaI digestion of two homologous fragments flanking the gene, using genomic […]

21
More

Transient neonatal hypothyroidism in a boy with unbalanced translocation t(8;16)

Luciana A. de A.
Secchi
,
Juliana F.
Mazzeu
,
Mara Santos
Córdoba
,
Íris
Ferrari
,
Helton Estrela
Ramos
,
Francisco de Assis Rocha
Neves

38
Transient neonatal hypothyroidism in a boy with unbalanced translocation t(8;16)

Transient neonatal hypothyroidism in a boy with unbalanced translocation t(8;16)

Luciana A. de A.
Secchi
,
Juliana F.
Mazzeu
,
Mara Santos
Córdoba
,
Íris
Ferrari
,
Helton Estrela
Ramos
,
Francisco de Assis Rocha
Neves

DOI: 10.1590/S0004-27302012000800017

Genetic defects resulting in deficiency of thyroid hormone synthesis can be found in about 10% of the patients with permanent congenital hypothyroidism, but the identification of genetic abnormalities in association with the transient form of the disease is extremely rare. We report the case of a boy with transient neonatal hypothyroidism that was undiagnosed in the neonatal screening, associated with extrathyroid malformations and mental retardation. The boy carries an unbalanced translocation t(8;16), and his maternal uncle had a similar phenotype. […]

38
More

Oncogenic osteomalacia: loss of hypophosphatemia might be the key to avoid misdiagnosis

Claudia V.
Chang
,
Sandro J.
Conde
,
Renata A. M.
Luvizotto
,
Vânia S.
Nunes
,
Milla C.
Bonates
,
[...], Célia R.
Nogueira

39
Oncogenic osteomalacia: loss of hypophosphatemia might be the key to avoid misdiagnosis

Oncogenic osteomalacia: loss of hypophosphatemia might be the key to avoid misdiagnosis

Claudia V.
Chang
,
Sandro J.
Conde
,
Renata A. M.
Luvizotto
,
Vânia S.
Nunes
,
Milla C.
Bonates
,
[...], Célia R.
Nogueira

DOI: 10.1590/S0004-27302012000800018

Diagnosing oncogenic osteomalacia is still a challenge. The disorder is characterized by osteomalacia caused by renal phosphate wasting and low serum concentration of 1,25-dihydroxyvitamin D3 occurring in the presence of a tumor that produces high levels of fibroblast growth factor 23. However, it is possible that the disease is much more misdiagnosed than rare. We present the case of a 42-year-old man with a long-term history of undiagnosed progressive muscle weakness. His laboratory results mainly showed low serum phosphate. Surgical […]

39
More

Maternally-inherited diabetes with deafness (MIDD) and hyporeninemic hypoaldosteronism

Patricia B.
Mory
,
Marcia C. dos
Santos
,
Claudio E.
Kater
,
Regina S.
Moisés

63
Maternally-inherited diabetes with deafness (MIDD) and hyporeninemic hypoaldosteronism

Maternally-inherited diabetes with deafness (MIDD) and hyporeninemic hypoaldosteronism

Patricia B.
Mory
,
Marcia C. dos
Santos
,
Claudio E.
Kater
,
Regina S.
Moisés

DOI: 10.1590/S0004-27302012000800019

Maternally-inherited diabetes with deafness (MIDD) is a rare form of monogenic diabetes that results, in most cases, from an A-to-G transition at position 3243 of mitochondrial DNA (m.3243A>G) in the mitochondrial-encoded tRNA leucine (UUA/G) gene. As the name suggests, this condition is characterized by maternally-inherited diabetes and bilateral neurosensory hearing impairment. A characteristic of mitochondrial cytopathies is the progressive multisystemic involvement with the development of more symptoms during the course of the disease. We report here the case of a […]

63
More

46,XX DSD and Antley-Bixler syndrome due to novel mutations in the cytochrome P450 oxidoreductase gene

Guilherme
Guaragna-Filho
,
Carla Cristina Telles de Sousa
Castro
,
Rodrigo Ribeiro De
Carvalho
,
Fernanda Borchers
Coeli
,
Lúcio Fábio Caldas
Ferraz
,
[...], Gil
Guerra-Junior

86
46,XX DSD and Antley-Bixler syndrome due to novel mutations in the cytochrome P450 oxidoreductase gene

46,XX DSD and Antley-Bixler syndrome due to novel mutations in the cytochrome P450 oxidoreductase gene

Guilherme
Guaragna-Filho
,
Carla Cristina Telles de Sousa
Castro
,
Rodrigo Ribeiro De
Carvalho
,
Fernanda Borchers
Coeli
,
Lúcio Fábio Caldas
Ferraz
,
[...], Gil
Guerra-Junior

DOI: 10.1590/S0004-27302012000800020

Deficiency of the enzyme P450 oxidoreductase is a rare form of congenital adrenal hyperplasia with characteristics of combined and partial impairments in steroidogenic enzyme activities, as P450 oxidoreductase transfers electrons to CYP21A2, CYP17A1, and CYP19A1. It results in disorders of sex development and skeletal malformations similar to Antley-Bixley syndrome. We report the case of a 9-year-old girl who was born with virilized genitalia (Prader stage V), absence of palpable gonads, 46,XX karyotype, and hypergonadotropic hypogonadism. During the first year of […]

86
More

The rare intracellular RET mutation p.Ser891Ala in an apparently sporadic medullary thyroid carcinoma: a case report and review of the literature

Carla Brauner
Blom
,
Lucieli
Ceolin
,
Mirian
Romitti
,
Débora
Siqueira
,
Ana Luiza
Maia

94
The rare intracellular RET mutation p.Ser891Ala in an apparently sporadic medullary thyroid carcinoma: a case report and review of the literature

The rare intracellular RET mutation p.Ser891Ala in an apparently sporadic medullary thyroid carcinoma: a case report and review of the literature

Carla Brauner
Blom
,
Lucieli
Ceolin
,
Mirian
Romitti
,
Débora
Siqueira
,
Ana Luiza
Maia

DOI: 10.1590/S0004-27302012000800021

Medullary thyroid carcinoma (MTC) is a malignant tumor originating from parafollicular C-cells and accounts for 4-10% of all thyroid carcinomas. MTC develops in either sporadic (75%) or hereditary form (25%). Mutations in the RET proto-oncogene are responsible for hereditary MTC and the rate of heritable disease among apparently sporadic MTC (sMTC) cases varies from 6 to 15%. RET genetic testing is now considered fundamental in MTC management but the extent of the molecular analysis required to exclude inherited disease is […]

94
More

New mutation in the PTEN gene in a Brazilian patient with Cowden’s syndrome

Erika U. de
Lima
,
Iberê C.
Soares
,
Debora L. S.
Danilovic
,
Suemi
Marui

85
New mutation in the PTEN gene in a Brazilian patient with Cowden’s syndrome

New mutation in the PTEN gene in a Brazilian patient with Cowden’s syndrome

Erika U. de
Lima
,
Iberê C.
Soares
,
Debora L. S.
Danilovic
,
Suemi
Marui

DOI: 10.1590/S0004-27302012000800022

Cowden syndrome is characterized by hamartomatous polyps, trichilemmomas, increased risk of developing neoplasms, and is associated with germline mutations in the PTEN gene. We searched for germline mutations in PTEN in a 49-year-old female patient who presented trichilemmoma with previous history of breast carcinoma, and thyroidectomy for a thyroid nodule. We also searched for somatic mutations in breast and thyroid tumoral tissues. DNA was extracted from peripheral leukocytes, paraffin samples of breast carcinoma, and cytological smears of thyroid nodule fine-needle […]

85
More

Search

Keywords

diabetes mellitus - 267 obesity - 222 insulin resistance - 117 metabolic syndrome - 109 Osteoporosis - 95 diabetes - 93 Thyroid cancer - 76 tratamento - 72 Type 1 diabetes - 64 treatment - 62 hypothyroidism - 62 resistência à insulina - 61 Growth hormone - 59 thyroid - 54 Type 1 diabetes mellitus - 54 Acromegaly - 52 hypertension - 47 type 2 diabetes mellitus - 44 Hyperthyroidism - 44 cancer - 41
Archives of Endocrinology and Metabolism

Rua Botucatu, 572 – conjuntos 81/83
Vila Clementino – São Paulo / SP
Zip Code: 04023-062
Phones: +55 (11) 5575-0311 / +55 (11) 99768-6933
E-mail: aem.editorial.office@endocrino.org.br

  • About
    • About the Journal
    • Cookies Policy
  • Editorial Board
  • Available Issues
  • Instructions for Authors
  • About
    • About the Journal
    • Cookies Policy
  • Editorial Board
  • Available Issues
  • Instructions for Authors
AEM SBEM

Santana Serviços Editoriais
Developed by
CABOVERDE
Gerenciar Consentimento de Cookies
We use cookies to optimize our website and our service.
Functional Always active
O armazenamento ou acesso técnico é estritamente necessário para a finalidade legítima de permitir a utilização de um serviço específico explicitamente solicitado pelo assinante ou utilizador, ou com a finalidade exclusiva de efetuar a transmissão de uma comunicação através de uma rede de comunicações eletrónicas.
Preferences
O armazenamento ou acesso técnico é necessário para o propósito legítimo de armazenar preferências que não são solicitadas pelo assinante ou usuário.
Estatísticas
O armazenamento ou acesso técnico que é usado exclusivamente para fins estatísticos. O armazenamento técnico ou acesso que é usado exclusivamente para fins estatísticos anônimos. Sem uma intimação, conformidade voluntária por parte de seu provedor de serviços de Internet ou registros adicionais de terceiros, as informações armazenadas ou recuperadas apenas para esse fim geralmente não podem ser usadas para identificá-lo.
Marketing
O armazenamento ou acesso técnico é necessário para criar perfis de usuário para enviar publicidade ou para rastrear o usuário em um site ou em vários sites para fins de marketing semelhantes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
Preferences
{title} {title} {title}